Renauld, A E <br/><br/>
Tumor necrosis factor expressed by primary hippocampal neurons and SH-SY5Y cells is regulated by alpha(2)-adrenergic receptor activation.  [electronic resource] 

 -  Journal of neuroscience research  Jan 2002 
 - 264-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0360-4012 
<br/><br/><label>Standard No.: </label>10.1002/jnr.10101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-2 Receptor Agonists<br/>Adrenergic alpha-Agonists--pharmacology<br/>Animals<br/>Brimonidine Tartrate<br/>Carcinogens--pharmacology<br/>Cell Differentiation--drug effects<br/>Cell Extracts--chemistry<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>Hippocampus--cytology<br/>Immunohistochemistry<br/>Male<br/>Membrane Potentials--drug effects<br/>Neurons--cytology<br/>Norepinephrine--metabolism<br/>Potassium--pharmacology<br/>Quinoxalines--pharmacology<br/>RNA, Messenger--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Adrenergic, alpha-2--metabolism<br/>Sympathomimetics--pharmacology<br/>Synaptic Transmission--physiology<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Tumor Necrosis Factor-alpha--genetics<br/>Tyramine--pharmacology